LIPPA ARNOLD (Exec Chairman, CSO) reported 2 transactions at RESPIRERX PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/24/2020ACC: 0001363763-20-000001
DirectorOfficer· Exec Chairman, CSO
Since Sep 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
4.50M acquired · 4.50M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.50M
Price / share
—
Trade value
—
% of position
752508.4%
3/22/2020
598.00→4.50M
Common Stock
Direct
Shares
−4.50M
Price / share
—
Trade value
—
% of position
100.0%
3/22/2020
4.50M→598.00
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/22/2020 | J · J | +4.50M | — | — | 752508.4% | 598.00 | 4.50M |
| Common Stock Direct | 3/22/2020 | G · Gift | −4.50M | — | — | 100.0% | 4.50M | 598.00 |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported